Statistics

Total Visits

Views
Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The GREKO II study34

Select a period of time:

Number of views in the range

Views
Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The GREKO II study20

Views

Views
May 20244
June 20241
July 20243
August 20243
September 20243
October 20245
November 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States16
Spain3
 

Top cities views

Views
Madrid3
Chicago2